IRIDEX CORP 4
4 · IRIDEX CORP · Filed May 18, 2016
Insider Transaction Report
Form 4
IRIDEX CORPIRIX
Steckel Ronald
VP, Operations
Transactions
- Sale
Common Stock
2016-05-17$12.79/sh−1,250$15,993→ 65,625 total - Exercise/Conversion
Stock Option Right to Buy
2016-05-17−1,250→ 5,000 totalExercise: $3.86From: 2013-02-01Exp: 2019-12-13→ Common Stock (1,250 underlying) - Sale
Common Stock
2016-05-17$12.82/sh−2,083$26,701→ 66,875 total - Exercise/Conversion
Common Stock
2016-05-17$3.99/sh+2,083$8,311→ 68,958 total - Exercise/Conversion
Common Stock
2016-05-17$3.86/sh+1,250$4,820→ 68,125 total - Sale
Common Stock
2016-05-17$12.82/sh−1,250$16,023→ 66,875 total - Exercise/Conversion
Stock Option Right to Buy
2016-05-17−2,083→ 0 totalExercise: $3.99From: 2013-04-16Exp: 2019-04-16→ Common Stock (2,083 underlying)
Footnotes (5)
- [F1]The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $12.67 to $12.97 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F2]The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $12.67 to $12.9 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
- [F4]The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.
- [F5]The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.